1223 related articles for article (PubMed ID: 19089967)
1. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
[TBL] [Abstract][Full Text] [Related]
2. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P
Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740
[TBL] [Abstract][Full Text] [Related]
4. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
[TBL] [Abstract][Full Text] [Related]
5. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
Sablotzki A; Hentschel T; Hofmann S; Simm A; Mühling J; Czeslick E
J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
[TBL] [Abstract][Full Text] [Related]
7. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.
Gorenflo M; Gu H; Xu Z
Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447
[TBL] [Abstract][Full Text] [Related]
8. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease.
Limsuwan A; Wanitkul S; Khosithset A; Attanavanich S; Samankatiwat P
Int J Cardiol; 2008 Oct; 129(3):333-8. PubMed ID: 18096256
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
Zhang C; Li Q; Liu T; Gu H
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
[TBL] [Abstract][Full Text] [Related]
11. [Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases].
Zhang CJ; Huang YG; Shen JJ; Huang T; Huang WH; Cui YL; Huang XS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):65-8. PubMed ID: 21418801
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of aerosolized iloprost and oxygen on assessment of pulmonary vasoreactivity in children with pulmonary hypertension.
Elkiran O; Karakurt C; Koçak G
Anadolu Kardiyol Derg; 2014 Jun; 14(4):383-8. PubMed ID: 24818629
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Braun S; Schrötter H; Schmeisser A; Strasser RH
Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
[TBL] [Abstract][Full Text] [Related]
15. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
17. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
[TBL] [Abstract][Full Text] [Related]
18. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
Theodoraki K; Rellia P; Thanopoulos A; Tsourelis L; Zarkalis D; Sfyrakis P; Antoniou T
Can J Anaesth; 2002 Nov; 49(9):963-7. PubMed ID: 12419726
[TBL] [Abstract][Full Text] [Related]
19. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
Voswinckel R; Enke B; Reichenberger F; Kohstall M; Kreckel A; Krick S; Gall H; Gessler T; Schmehl T; Ghofrani HA; Schermuly RT; Grimminger F; Rubin LJ; Seeger W; Olschewski H
J Am Coll Cardiol; 2006 Oct; 48(8):1672-81. PubMed ID: 17045906
[TBL] [Abstract][Full Text] [Related]
20. [Inhaled iloprost during acute pulmonary vasodilator testing for preoperative assessment of surgical operability of congenital heart disease with severe pulmonary hypertension].
Gu H; Li QQ; Zhang C; Liu TY; Zhuo L; Liu HJ; Guo BJ; Hou J; Zhang H; Yi F; Luo Y
Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):727-30. PubMed ID: 20646485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
